Fcγ Receptor Iib–Deficient Mice Develop Goodpasture's Syndrome upon Immunization with Type IV Collagen
Akira Nakamura(Shinshu University), Toshiyuki Takai(Tohoku University), Azusa Ujike(Tohoku University), Jeffrey V. Ravetch(Laboratory of Molecular Genetics), Masao Ono(Tohoku University), Toshihiro Nukiwa(Tohoku University), Takae Yuasa(Tohoku University)
Cited by 212
Related Papers
Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR
|New England Journal of Medicine|2010|5.6k
Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming
|Cancer Cell|2012|1.4k
Double-blind, Placebo-controlled Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
|American Journal of Respiratory and Critical Care Medicine|2005|953
Erlotinib plus bevacizumab versus erlotinib alone in patients with EGFR-positive advanced non-squamous non-small-cell lung cancer (NEJ026): interim analysis of an open-label, randomised, multicentre, phase 3 trial
|The Lancet Oncology|2019|636
The role of IgG Fc receptors in antibody-dependent enhancement
|Nature reviews. Immunology|2020|634